Up a level |
Jacobsen, Frank, Taskin, Billurvan, Melling, Nathaniel, Sauer, Charlotte, Wittmer, Corinna, Hube-Magg, Claudia, Kluth, Martina, Simon, Ronald, Pehrke, Dirk, Beyer, Burkhard et al (show 8 more authors)
(2017)
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.
BMC CANCER, 17 (1).
504-.
Jones, Robert P ORCID: 0000-0001-5608-001X, Mielgo, Ainhoa, Schmid, Michael ORCID: 0000-0002-3445-0013, Bury, Danielle, Andrews, Timothy, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Shackcloth, Michael, J. S. Cross, Timothy, Fenwick, Stephen, Malik, Hassan Z et al (show 4 more authors)
(2023)
PINCER (A Platform Study for solId orgaN CancERs): an agile pan-network platform study to deliver high-quality translational research.
BRITISH JOURNAL OF SURGERY, 110 (9).
pp. 1108-1111.
Elsesy, Mohamed E, Oh-Hohenhorst, Su Jung, Oing, Christoph, Eckhardt, Alicia, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Alawi, Malik, Mueller, Christian, Schueller, Ulrich, Maurer, Tobias, von Amsberg, Gunhild et al (show 3 more authors)
(2023)
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.
MOLECULAR ONCOLOGY, 17 (6).
pp. 1129-1147.
Grupp, Katharina, Hofmann, Bianca, Kutup, Asad, Bachmann, Kai, Bogoevski, Dean, Melling, Nathaniel, Uzunoglu, Faik Guntac, El Gammal, Alexander Tarek, Koop, Christina, Simon, Ronald et al (show 7 more authors)
(2018)
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
BMC CANCER, 18 (1).
1106-.
Elsesy, Mohamed E, Oh-Hohenhorst, Su Jung, Loeser, Anastassia, Oing, Christoph, Mutiara, Sally, Koecher, Sabrina, Meien, Stefanie, Zielinski, Alexandra, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Tilki, Derya et al (show 6 more authors)
(2020)
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair.
CANCERS, 12 (9).
E2467-.